「Test」の版間の差分

ナビゲーションに移動 検索に移動
413 バイト除去 、 2013年10月8日 (火)
編集の要約なし
編集の要約なし
編集の要約なし
46行目: 46行目:
|[[wj:リボース|リボース]]||FLIPrib|| 2003 || 3-1 || <ref><pubmed>14550551</pubmed></ref>
|[[wj:リボース|リボース]]||FLIPrib|| 2003 || 3-1 || <ref><pubmed>14550551</pubmed></ref>
|-
|-
|rowspan="26" | Kinase || [[カルシウム/カルモジュリン依存製タンパク質キナーゼII]] ([[CaMKII]]) ||Camui α, green-Camui α, Camk2a reporter|| 2005, 2009, 2011, 2013 || 3-1 || <ref><pubmed>15788767</pubmed></ref><ref><pubmed> 19295602</pubmed></ref><ref><pubmed> 23602566</pubmed></ref><ref><pubmed> 21506563</pubmed></ref>
|rowspan="26" | キナーゼ || [[カルシウム/カルモジュリン依存製タンパク質キナーゼII]] ([[CaMKII]]) ||Camui α, green-Camui α, Camk2a reporter|| 2005, 2009, 2011, 2013 || 3-1 || <ref><pubmed>15788767</pubmed></ref><ref><pubmed> 19295602</pubmed></ref><ref><pubmed> 23602566</pubmed></ref><ref><pubmed> 21506563</pubmed></ref>
|-
|-
| [[Src]] ||Srcus|| 2005, 2005, 2007 || 3-3 || <ref><pubmed>11752449</pubmed></ref><ref><pubmed> 15846350</pubmed></ref><ref><pubmed> 17284441</pubmed></ref>
| [[Src]] ||Srcus|| 2005, 2005, 2007 || 3-3 || <ref><pubmed>11752449</pubmed></ref><ref><pubmed> 15846350</pubmed></ref><ref><pubmed> 17284441</pubmed></ref>
98行目: 98行目:
| DAPK1 ||DAPK1(334)-F40|| 2011 || 3-1 || <ref><pubmed>21506563</pubmed></ref>
| DAPK1 ||DAPK1(334)-F40|| 2011 || 3-1 || <ref><pubmed>21506563</pubmed></ref>
|-
|-
| Phosphatase || Calcineurin ||CaNAR1|| 2008, 2013 || 3-1 || <ref><pubmed>23602566</pubmed></ref><ref><pubmed> 18493642</pubmed></ref>
| ホスファターゼ || Calcineurin ||CaNAR1|| 2008, 2013 || 3-1 || <ref><pubmed>23602566</pubmed></ref><ref><pubmed> 18493642</pubmed></ref>
|-
|-
| Small GTPase || Ras ||Raichu-Ras, Fras|| 2001, 2006 || 3-2,2 || <ref><pubmed>16429133</pubmed></ref><ref name=ref11429608><pubmed> 11429608</pubmed></ref>
|rowspan="8" | Small GTPase || Ras ||Raichu-Ras, Fras|| 2001, 2006 || 3-2,2 || <ref><pubmed>16429133</pubmed></ref><ref name=ref11429608><pubmed> 11429608</pubmed></ref>
|-
|-
| Small GTPase || Rap ||Raichu-Rap|| 2001 || 3-2 || <ref name=ref11429608></ref>
| Rap ||Raichu-Rap|| 2001 || 3-2 || <ref name=ref11429608></ref>
|-
|-
| Small GTPase || Rac ||Raichu-Rac1|| 2004 || 3-2 || <ref><pubmed>14570905</pubmed></ref>
| Rac ||Raichu-Rac1|| 2004 || 3-2 || <ref><pubmed>14570905</pubmed></ref>
|-
|-
| Small GTPase || Rab5 ||Raichu-Rab5|| 2008 || 3-2 || <ref><pubmed>18385674</pubmed></ref>
| Rab5 ||Raichu-Rab5|| 2008 || 3-2 || <ref><pubmed>18385674</pubmed></ref>
|-
|-
| Small GTPase || Rho ||Raichu-RhoA|| 2003, 2011 || 3-2, 2 || <ref><pubmed>21423166</pubmed></ref><ref><pubmed> 12860967</pubmed></ref>
| Rho ||Raichu-RhoA|| 2003, 2011 || 3-2, 2 || <ref><pubmed>21423166</pubmed></ref><ref><pubmed> 12860967</pubmed></ref>
|-
|-
| Small GTPase || Cdc42 ||Raichu-cdc42|| 2004, 2011 || 3-2, 2 || <ref><pubmed>14570905</pubmed></ref><ref><pubmed> 21423166</pubmed></ref>
| Cdc42 ||Raichu-cdc42|| 2004, 2011 || 3-2, 2 || <ref><pubmed>14570905</pubmed></ref><ref><pubmed> 21423166</pubmed></ref>
|-
|-
| Small GTPase || Ral ||Raichu-Ral|| 2004 || 3-3 || <ref><pubmed>15034142</pubmed></ref>
| Ral ||Raichu-Ral|| 2004 || 3-3 || <ref><pubmed>15034142</pubmed></ref>
|-
|-
| Small GTPase || TC10 ||Raichu-TC10|| 2006 || 3-2 || <ref><pubmed>16950130</pubmed></ref>
| TC10 ||Raichu-TC10|| 2006 || 3-2 || <ref><pubmed>16950130</pubmed></ref>
|-
|-
| Signal transduction || RCC1(GEF of Ran) ||CFP-RCC1-YFP|| 2008 || 3-1 || <ref><pubmed>18762580</pubmed></ref>
|rowspan="6" | Signal transduction || RCC1(GEF of Ran) ||CFP-RCC1-YFP|| 2008 || 3-1 || <ref><pubmed>18762580</pubmed></ref>
|-
|-
| Signal transduction || CrkII phosphorylation ||Picchu|| 2001 || 3-1 || <ref><pubmed>11406630</pubmed></ref>
| CrkII phosphorylation ||Picchu|| 2001 || 3-1 || <ref><pubmed>11406630</pubmed></ref>
|-
|-
| Signal transduction || N-WASP ||Stinger|| 2004 || 3-1 || <ref><pubmed>15084285</pubmed></ref><ref><pubmed> 14732696</pubmed></ref>
| N-WASP ||Stinger|| 2004 || 3-1 || <ref><pubmed>15084285</pubmed></ref><ref><pubmed> 14732696</pubmed></ref>
|-
|-
| Signal transduction || Adrenergic receptor ||α<sub>2A</sub>AR-cam|| 2003 || 3-1 || <ref name=ref12808462><pubmed>12808462</pubmed></ref>
| Adrenergic receptor ||α<sub>2A</sub>AR-cam|| 2003 || 3-1 || <ref name=ref12808462><pubmed>12808462</pubmed></ref>
|-
|-
| Signal transduction || Parathyroid hormone receptor ||PTHR-cam|| 2003 || 3-1 || <ref name=ref12808462></ref>
| Parathyroid hormone receptor ||PTHR-cam|| 2003 || 3-1 || <ref name=ref12808462></ref>
|-
|-
| Signal transduction || Plasma membrane Calcium pump ||BFP-PMCA-GFP|| 2007 || 3-1 || <ref><pubmed>17901055</pubmed></ref>
| Plasma membrane Calcium pump ||BFP-PMCA-GFP|| 2007 || 3-1 || <ref><pubmed>17901055</pubmed></ref>
|-
|-
| Acetylation || Histone acetylation ||Histac|| 2004, 2009 || 3-3 || <ref><pubmed>15137760</pubmed></ref><ref><pubmed> 19805290</pubmed></ref>
| Acetylation || Histone acetylation ||Histac|| 2004, 2009 || 3-3 || <ref><pubmed>15137760</pubmed></ref><ref><pubmed> 19805290</pubmed></ref>
|-
|-
| Lipid || Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) ||Fllip, FLIMPA|| 2003 || 3-4 || <ref><pubmed>14528311</pubmed></ref>
|rowspan="6" | Lipid || Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) ||Fllip, FLIMPA|| 2003 || 3-4 || <ref><pubmed>14528311</pubmed></ref>
|-
|-
| Lipid || Phosphatidylinositol (4,5)-bisphosphate (PIP2) ||Pippi-PI(4,5)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081><pubmed>18685081</pubmed></ref>
| Phosphatidylinositol (4,5)-bisphosphate (PIP2) ||Pippi-PI(4,5)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081><pubmed>18685081</pubmed></ref>
|-
|-
| Lipid || Phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) ||Pippi-PI(3,4)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081></ref>
| Phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) ||Pippi-PI(3,4)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081></ref>
|-
|-
| Lipid || Phosphatidylinositol 4-phosphate (PI4P) ||Pippi-PI(4)P|| 2008 || 3-4 || <ref name=ref18685081></ref>
| Phosphatidylinositol 4-phosphate (PI4P) ||Pippi-PI(4)P|| 2008 || 3-4 || <ref name=ref18685081></ref>
|-
|-
| Lipid || Phosphatidic acid ||Pii|| 2010 || 3-4 || <ref><pubmed>20826779</pubmed></ref>
| Phosphatidic acid ||Pii|| 2010 || 3-4 || <ref><pubmed>20826779</pubmed></ref>
|-
|-
| Lipid || Diacylglycerol (DAG) ||Daglas, DIGDA|| 2006, 2008 || 3-4 || <ref><pubmed>18685081</pubmed></ref><ref><pubmed> 16990811</pubmed></ref>
| Diacylglycerol (DAG) ||Daglas, DIGDA|| 2006, 2008 || 3-4 || <ref><pubmed>18685081</pubmed></ref><ref><pubmed> 16990811</pubmed></ref>
|-
|-
| Protein interaction || Actin || ||2004, 2008 || 2 || <ref><pubmed>15361876</pubmed></ref><ref><pubmed> 18512154</pubmed></ref>
|rowspan="6" | Protein interaction || Actin || ||2004, 2008 || 2 || <ref><pubmed>15361876</pubmed></ref><ref><pubmed> 18512154</pubmed></ref>
|-
|-
| Protein interaction || PDK1-Akt interaction || ||2007 || 2 || <ref><pubmed>17407381</pubmed></ref>
| PDK1-Akt interaction || ||2007 || 2 || <ref><pubmed>17407381</pubmed></ref>
|-
|-
| Protein interaction || Protein tyrosine phosphatase 1B-receptor tyrosine kinases (PTP 1B-RTKs) interaction || || 2002 || 2 || <ref><pubmed>11872838</pubmed></ref>
| Protein tyrosine phosphatase 1B-receptor tyrosine kinases (PTP 1B-RTKs) interaction || || 2002 || 2 || <ref><pubmed>11872838</pubmed></ref>
|-
|-
| Protein interaction || Breast cancer resistance protein/ATP-binding cassette sub-family G member) BCRP/ABCG || ||2010 || 2 || <ref><pubmed>20622991</pubmed></ref>
| Breast cancer resistance protein/ATP-binding cassette sub-family G member) BCRP/ABCG || ||2010 || 2 || <ref><pubmed>20622991</pubmed></ref>
|-
|-
| Protein interaction || Cofiin-actin interaction || ||2008 || 2 || <ref><pubmed>17993279</pubmed></ref>
| Cofiin-actin interaction || ||2008 || 2 || <ref><pubmed>17993279</pubmed></ref>
|-
|-
| Protein interaction || PTEN-Myosin V interaction || ||2009 || 2 || <ref><pubmed>19767745</pubmed></ref>
| PTEN-Myosin V interaction || ||2009 || 2 || <ref><pubmed>19767745</pubmed></ref>
|-
|-
| Protease || Caspase-3 ||EGFP-DEVD-EBFP|| 1998 || 1 || <ref><pubmed>9518501</pubmed></ref>
|rowspan="8" | Protease || Caspase-3 ||EGFP-DEVD-EBFP|| 1998 || 1 || <ref><pubmed>9518501</pubmed></ref>
|-
|-
| Protease || Caspase-8 ||CFP-c3-YFP-c6-mRFP|| 2002 || 1 || <ref><pubmed>12409609</pubmed></ref>
| Caspase-8 ||CFP-c3-YFP-c6-mRFP|| 2002 || 1 || <ref><pubmed>12409609</pubmed></ref>
|-
|-
| Protease || Caspase-9 ||SCAT9|| 2011 || 1 || <ref><pubmed>21637712</pubmed></ref>
| Caspase-9 ||SCAT9|| 2011 || 1 || <ref><pubmed>21637712</pubmed></ref>
|-
|-
| Protease || Caspase-7 ||VDEVDc|| 2006 || 1 || <ref><pubmed>17946841</pubmed></ref>
| Caspase-7 ||VDEVDc|| 2006 || 1 || <ref><pubmed>17946841</pubmed></ref>
|-
|-
| Protease || Matrix Metalloproteinase (MMP) ||YFP-MSS-CFP<sup>display</sup>, MTI-MMP-FRET biosensor|| 2007, 2008 || 1 || <ref><pubmed>17187878</pubmed></ref><ref><pubmed> 18441011</pubmed></ref>  
| Matrix Metalloproteinase (MMP) ||YFP-MSS-CFP<sup>display</sup>, MTI-MMP-FRET biosensor|| 2007, 2008 || 1 || <ref><pubmed>17187878</pubmed></ref><ref><pubmed> 18441011</pubmed></ref>  
|-
|-
| Protease || Protease activity (Factor Xa) || ||1996 || 1 || <ref><pubmed>8707050</pubmed></ref>
| Protease activity (Factor Xa) || ||1996 || 1 || <ref><pubmed>8707050</pubmed></ref>
|-
|-
| Protease || Calpain activity ||pYSCS|| 2000 || 1 || <ref><pubmed>10688895</pubmed></ref>
| Calpain activity ||pYSCS|| 2000 || 1 || <ref><pubmed>10688895</pubmed></ref>
|-
|-
| Protease || Presenilin ||GFP-PSI-RFP|| 2009 || 3-1 || <ref><pubmed>19924286</pubmed></ref>
| Presenilin ||GFP-PSI-RFP|| 2009 || 3-1 || <ref><pubmed>19924286</pubmed></ref>
|-
|-
| Other || Strain sensor ||stFRET|| 2008 || 3-1 || <ref><pubmed>18479457</pubmed></ref>
|rowspan="5" | Other || Strain sensor ||stFRET|| 2008 || 3-1 || <ref><pubmed>18479457</pubmed></ref>
|-
|-
| Other || Membrane potential ||VSFP, Mermaid, ArcLight, VSFP-Butterfly|| 2001, 2008, 2012 || 3-1 || <ref><pubmed>11454036</pubmed></ref><ref><pubmed> 18622396</pubmed></ref><ref><pubmed> 22958819</pubmed></ref>
| Membrane potential ||VSFP, Mermaid, ArcLight, VSFP-Butterfly|| 2001, 2008, 2012 || 3-1 || <ref><pubmed>11454036</pubmed></ref><ref><pubmed> 18622396</pubmed></ref><ref><pubmed> 22958819</pubmed></ref>
|-
|-
| Other || Myosin II ||GSldCB|| 1998, 2006 || 3-1 || <ref><pubmed>9845076</pubmed></ref><ref><pubmed> 16939200</pubmed></ref>
| Myosin II ||GSldCB|| 1998, 2006 || 3-1 || <ref><pubmed>9845076</pubmed></ref><ref><pubmed> 16939200</pubmed></ref>
|-
|-
| Other || HIV Rev protein ||YRGnC-11ad|| 2005 || 3-1 || <ref><pubmed>16013840</pubmed></ref>
| HIV Rev protein ||YRGnC-11ad|| 2005 || 3-1 || <ref><pubmed>16013840</pubmed></ref>
|-
|-
| Other || Redox ||Redoxfluor, Gaskins|| 2010, 2011 || 3-1 || <ref><pubmed>20498274</pubmed></ref><ref><pubmed> 21606117</pubmed></ref>
|| Redox ||Redoxfluor, Gaskins|| 2010, 2011 || 3-1 || <ref><pubmed>20498274</pubmed></ref><ref><pubmed> 21606117</pubmed></ref>
|}
|}


案内メニュー